loadpatents
name:-0.0097031593322754
name:-0.0091838836669922
name:-0.0045030117034912
Fandrick; Daniel Robert Patent Filings

Fandrick; Daniel Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fandrick; Daniel Robert.The latest application filed is for "novel chiral dihydrobenzooxaphosphole ligands and synthesis thereof".

Company Profile
3.6.9
  • Fandrick; Daniel Robert - Danbury CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Chiral dihydrobenzooxaphosphole ligands and synthesis thereof
Grant 10,544,177 - Desrosiers , et al. Ja
2020-01-28
Novel Chiral Dihydrobenzooxaphosphole Ligands And Synthesis Thereof
App 20190144475 - DESROSIERS; Jean-Nicolas ;   et al.
2019-05-16
Chiral dihydrobenzooxaphosphole ligands and synthesis thereof
Grant 10,221,203 - Desrosiers , et al.
2019-03-05
Pyrazolyl-substituted heteroaryls and their use as medicaments
Grant 10,155,751 - Hoffmann , et al. Dec
2018-12-18
Novel Chiral Dihydrobenzooxaphosphole Ligands And Synthesis Thereof
App 20180155375 - Desrosiers; Jean-Nicolas ;   et al.
2018-06-07
New Pyrazolyl-substituted Heteroaryls and their use as Medicaments
App 20180148433 - Hoffmann; Matthias ;   et al.
2018-05-31
Methods of making diastereomeric organic compounds
Grant 8,916,701 - Fandrick , et al. December 23, 2
2014-12-23
Methods Of Making Diastereomeric Organic Compounds
App 20140135493 - Fandrick; Daniel Robert ;   et al.
2014-05-15
Stereoselective Synthesis Of Tapentadol And Its Salts
App 20130150622 - FANDRICK; Daniel Robert ;   et al.
2013-06-13
Pyridinyl Compounds Useful As Intermediates
App 20120136158 - COOK; Brian Nicholas ;   et al.
2012-05-31
Azaindazole Compounds As CCR1 Receptor Antagonists
App 20120035370 - COOK; Brian Nicholas ;   et al.
2012-02-09
Azaindazole compounds as CCR1 receptor antagonists
Grant 7,879,873 - Cook , et al. February 1, 2
2011-02-01
Azaindazole Compounds As CCR1 Receptor Antagonists
App 20100093724 - COOK; Brian Nicholas ;   et al.
2010-04-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed